%0 Journal Article
%T The ocular immunological alterations in the process of high-risk corneal transplantation rejection.
%A Chi H
%A Wei C
%A Ma L
%A Yu Y
%A Zhang T
%A Shi W
%J Exp Eye Res
%V 245
%N 0
%D 2024 Aug 11
%M 38871165
%F 3.77
%R 10.1016/j.exer.2024.109971
%X <B>OBJECTIVE: </B>This study aims to reveal the immunopathogenesis of the high-risk corneal transplantation using a comparative proteomic approach.<BR><B>METHODS: </B>The immunological properties of ocular tissues (including corneal grafts, aqueous humour, and iris-ciliary body) were analysed using a high-risk rabbit corneal transplantation model employing a comparative proteomic approach.<BR><B>RESULTS: </B>The corneal grafts revealed a dramatic increase in the immune response both at the early (postoperative day 7) and rejection stages, along with the appearance of transplantation stress-induced cellular senescence in the early stage. The aqueous humour (AH) displayed persistent pathological alterations, indicated by the significant enrichment of complement and coagulation cascades pathway in the early stage and interleukin (IL)-17 signalling pathway in the rejection stage. More surprisingly, the pronounced elevation of immune response was also observed in the iris-ciliary body (I-CB) tissues at the early and rejection stages. The enriched immune-related pathways were associated with antigen processing and presentation, complement and coagulation cascades, and IL-17 signalling pathway. Furthermore, proteomic analysis revealed that the implantation of Cyclosporine A drug delivery system (CsA-DDS) into the anterior chamber obviously mitigated corneal transplantation rejection by inhibiting immunoreaction both in the corneal grafts and I-CB tissues.<BR><B>CONCLUSIONS: </B>The results highlighted the involvement of intraocular immunity both in the grafts and I-CB tissues during corneal transplantation rejection, further suggesting the anterior chamber as an optimal drug-delivery site for its treatment.